Otsuka Pakistan Limited (OTSU) will suspend its production operations from December 20, 2025, to January 4, 2026, to carry out scheduled annual preventive maintenance.
The company confirmed that manufacturing activities will resume on January 5, 2026.
The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan.
Editorial & Legal Practice Group
Authored and reviewed by the corporate law and tax litigation practice group at Javid Law Associates. Our team comprises High Court advocates, corporate legal advisors, and authorized tax practitioners across Pakistan.
Advocates High Court & Tax Counsel
Jurisdiction: Pakistan